J M Zhu1, W Huffer, A C Alfrey
1Department of Medicine, Denver V.A. Hospital, Colorado.
This study investigated how aluminum affects the ability of bone matrix to promote new bone formation when implanted in rats. Decalcified femur sections were treated with different concentrations of aluminum chloride and implanted for 28 days. Results showed that aluminum-treated matrix had lower calcium content and reduced bone remodeling compared to the control group. Histological analysis revealed minimal osteoblastic and osteoclastic activity in aluminum-treated samples. The researchers propose that aluminum forms cross-links between collagen fibrils, reducing matrix inductivity. Chelation partially reversed these effects, suggesting a reversible mechanism. The findings support the idea that aluminum-induced changes in collagen or inductive proteins may explain its role in osteomalacia.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Aluminum exposure has been linked to bone disorders, but its direct impact on bone matrix inductive properties remains unclear. Prior research has shown that aluminum can interfere with bone mineralization and collagen structure. However, the mechanism by which aluminum affects the osteoinductive capacity of bone matrix is not fully understood. There is a gap in knowledge regarding how aluminum alters the biochemical and structural integrity of bone implants. This uncertainty drives the need for experimental models to assess aluminum's influence on bone remodeling and inductive properties. Current studies often focus on systemic effects rather than localized interactions with bone matrix. No prior work had resolved whether aluminum binding to collagen or inductive proteins is responsible for its effects. This gap motivated the current investigation into aluminum's role in bone matrix behavior.
Purpose Of The Study:
This study aimed to determine how aluminum affects the inductive properties of bone matrix when implanted in rats. The researchers focused on whether aluminum alters collagen structure or inductive protein activity. They used decalcified femur sections treated with aluminum chloride solutions of different concentrations. The goal was to assess the impact of aluminum on bone formation and remodeling. They also wanted to determine if chelation could reverse aluminum's effects. The study sought to clarify whether aluminum-induced cross-linking of collagen or interference with inductive proteins is the primary mechanism. By comparing aluminum-treated and control groups, the researchers aimed to isolate the role of aluminum in bone matrix function. Their findings could help explain the pathogenesis of aluminum-related bone diseases.
The researchers propose that aluminum forms intermolecular cross-links between collagen fibrils, reducing matrix inductive properties.
Aluminum content was measured after 28 days of implantation in subcutaneous pouches in rats.
Resistance to collagenase suggests aluminum-induced cross-linking of collagen fibrils, altering matrix structure.
Chelation partially restored bone inductive properties, indicating that aluminum binding is reversible.
Main Methods:
Decalcified femur sections were immersed in aluminum chloride solutions of varying concentrations for 24 hours. The sections were then implanted into subcutaneous pouches in rats for 28 days. Aluminum and calcium content in the matrix were measured post-implantation. Bone histology was analyzed to assess osteoblastic and osteoclastic activity. Tetracycline labeling was used to evaluate bone formation. The researchers also tested the effect of chelation on bone inductive properties. Collagenase degradation resistance was measured to assess collagen cross-linking. The study compared results across three treatment groups and a control group to determine the role of aluminum in matrix behavior.
Main Results:
Matrix pretreated with 0.1 M AlCl3 had an aluminum content of 3232 ± 1020 mg/kg after 28 days. The 0.01 M AlCl3 group had 51 ± 6 mg/kg aluminum. Matrix calcium content was 794 ± 539 mmol/kg in the 0.1 M group and 3038 ± 692 mmol/kg in the 0.01 M group. Control group calcium levels were 4252 ± 579 mmol/kg. Histology showed minimal osteoblastic and osteoclastic activity in aluminum-treated groups. Tetracycline labeling and bone formation were absent in these groups. Control group implants showed extensive remodeling and bone formation. Chelation partially restored inductive properties, suggesting aluminum binding is reversible.
Conclusions:
Aluminum-treated bone matrix showed reduced inductive properties compared to the control. The absence of osteoblastic and osteoclastic activity suggests aluminum inhibits bone remodeling. Aluminum's resistance to collagenase degradation implies cross-linking between collagen fibrils. Chelation partially reversed these effects, supporting a reversible mechanism. The findings suggest aluminum may interfere with inductive proteins in the matrix. The study supports the idea that aluminum-induced cross-linking disrupts bone matrix function. These results align with the authors' hypothesis about aluminum's role in osteomalacia. The findings highlight the need for further research on aluminum's effects on bone implants.
The calcium content was 794 ± 539 mmol/kg in the 0.1 M AlCl3 pretreated group.
The authors suggest that aluminum may interfere with collagen cross-linking or inductive proteins in the bone matrix.